| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000016912 |
| Receipt No. | R000018016 |
| Official scientific title of the study | Evaluation of exocrine pancreatic function after esophagectomy and effect using pancrelipase |
| Date of disclosure of the study information | 2015/04/01 |
| Last modified on | 2017/10/30 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Evaluation of exocrine pancreatic function after esophagectomy and effect using pancrelipase | |
| Title of the study (Brief title) | Exocrine pancreatic function after esophagectomy and effect of pancrelipase | |
| Region |
|
|
| Condition | |||
| Condition | esophageal cancer | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | The aim of this study is to evaluate the efficacy and safety of pancrelipase after operation of esophageal cancer who has low exocrine pancreatic function. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase II |
| Assessment | |
| Primary outcomes | The ratio of frequency of the stool below two times a day.
The ratio of bristol scale below 4. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | orally taking pancrelipase
terms: three months amounts: 600mg/meal times: ever time after meal |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Esophageal cancer patients who is after esophagectomy and coming for follow-up visit.
2) Patients with lower fecal elastase1 than 200mg/g and has higher Bristol scale than 6. 3) Patients who had got informed consent. |
|||
| Key exclusion criteria | 1)Patients who is treating by chemotherapy or radiotherapy.
2)Patients who are allergic to swine protein. 3)Patients who had over 5kg of weight movement. 4)Patients who has a possibility of pregnant or now pregnant, or while nursing. 5)Patients with severe infection. 6)Patients who did not give consent to this research. 7)Patients who are suspected of chronic pancreatitis, after pancreatectomy and other cause of exocrine pancreatic dysfunction. 8)Patients with dyschezia caused by irritable bowel syndrome or inflammatory bowel disease. 9)Patients treated by enteral alimentation. |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Yoshihiro Kakeji |
| Organization | Kobe University |
| Division name | Division of Gastrointestinal Surgery |
| Address | Kusunoki-chou 7-5-2, Chuo-ku, Kobe |
| TEL | 078-382-5925 |
| kakeji@med.kobe-u.ac.jp | |
| Public contact | |
| Name of contact person | Tetsu Nakamura |
| Organization | Kobe University |
| Division name | Division of Gastrointestinal Surgery |
| Address | Kusunoki-chou 7-5-2, Chuo-ku, Kobe |
| TEL | 078-382-5925 |
| Homepage URL | |
| tetsun@med.kobe-u.ac.jp | |
| Sponsor | |
| Institute | Kobe University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000018016 |